LC
AVNS

Landaas & Company’s Avanos Medical AVNS Stock Holding History

Landaas & Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-87
Closed -$5K – 81
2018
Q2 		$5K Buy
+87
New +$4.6K ﹤0.01% 294
2018
Q1 		– Sell
-87
Closed -$4K – 75
2017
Q4 		$4K Hold
87
– – ﹤0.01% 291
2017
Q3 		$4K Buy
+87
New +$3.71K ﹤0.01% 289

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Landaas & Company's AVNS Position: Q3 2018 in Review

Landaas & Company sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 87 shares — an estimated $5K sold.

Landaas & Company first reported a position in AVNS in Q3 2017 and held it in 3 quarters. The position peaked at $5K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Landaas & Company reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 87 Avanos Medical shares in Q3 2018, an estimated $5K.
  • Landaas & Company first reported a position in Avanos Medical in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Avanos Medical position peaked at $5K in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.